EditorialNosological status and definition of schizophrenia: Some considerations for DSM-V and ICD-11
Introduction
The need to distinguish between different medical conditions that cause human suffering is the reason to classify medical disorders. A useful nosological system (literally, system of classification of disease) (Merriam-Webster, 2008) enables clinicians to provide specific treatments for distinct medical causes of human dis-ease and/or disability whose effects are precise and predictable as also provide guidance to patients and families about the likely course and outcome of such suffering. Additionally, it enables researchers to study circumscribed conditions and elucidate the nature of defined disease entities. Although there have been several efforts to provide a useful nomenclature from the times of the Ayurveda and Hippocrates, our modern system of classification derives from the work of a committee chaired by Dr. Jacques Bertillon that prepared a system of classification of the causes of death which was adopted by the International Statistical Institute in 1893 (Bertillon, 1912). Since that time, this system has been considerably expanded in scope and size and has undergone ten revisions (ICD 1-10); the number of listed conditions has multiplied from 179 in ICD-1 to over 13,000 in the current version of ICD-10 (World Health Organization, 1992).
In the sixth revision of this system (ICD-6) (World Health Organization, 1949) there was a substantial reconceptualization of the section relating to mental disorders (section V). In subsequent revisions (ICD 7–10), changes in this section have been relatively small although a glossary has been added and changes in diagnostic criteria made. Additionally in the most recent revision, three versions of section V of the ICD-10 are provided—the core version (World Health Organization, 1992) and versions for research (World Health Organization, 1993) and the general practitioner (Ustun et al., 1995). Since the first edition of the American Diagnostic and Statistical Manual of Mental Disorders (DSM-1) (American Psychiatric Association, 1952), there have been five revisions (DSM-II, DSM-III, DSM-III-R, DSM-IV, and the current DSM-IV-TR) (American Psychiatric Association, 1968, American Psychiatric Association, 1980, American Psychiatric Association, 1987, American Psychiatric Association, 1994, American Psychiatric Association, 2000). Whereas there was considerable divergence between section V of ICD-6 and DSM-I, there is now considerable similarity between DSM-IV-TR and section V of ICD-10. The process of revising both DSM-IV-TR and ICD-10 are underway and DSM-V is expected to be released in 2012 whereas ICD-11 is expected to be finalized by 2014. Current versions of both ICD-10 and DSM-IV-TR are marked by considerable complexity, variable validity, limitations in clinical and research utility, problems of burgeoning comorbidity, and occasionally blurred boundaries between normality and disease (Maj, 2000, Maj, 2005). As with other medical disorders, any meaningful nosological system of mental disorders must be valid, reliable, and useful (Table 1) (Kendell and Jablensky, 2003) and efforts to revise the DSM and ICD systems of classification of mental disorders towards this objective must address these limitations.
In the remainder of this essay, we briefly summarize the challenges we face with specific reference to the definition and nosological status of schizophrenia.
Section snippets
Definition and nosological status of schizophrenia
Although we have studied schizophrenia as a specific disease entity for the past century, its precise nature (core definition, precise boundaries, causes and pathogenesis) remains undefined (Jansson and Parnas, 2007). Since its demarcation as dementia praecox by Kraepelin (1971) and schizophrenia by Bleuler (1950) its definitions have varied and its boundaries have expanded and receded over the past century. Despite vigorous study over this time, its etiology and pathophysiology are relatively
From schizophrenic reaction to schizophrenia: DSM-1 to DSM-IV-TR
In the 1950s in the United States of America, psychiatric practice was primarily influenced by psychoanalytic principles and the philosophy of Adolf Meyer who believed that mental disorders emerge out of life trajectories. Called schizophrenic reaction in DSM-1 (American Psychiatric Association, 1952), disturbances in concept formation and reality relationships defined this construct. The 1950s and 1960s marked an era of psychiatric expansionism as also the introduction of the first effective
Implications for DSM-V and ICD-11
There is a strong desire to incorporate burgeoning genetic and other neurobiological findings into the DSM-V definition of schizophrenia. While retaining the high reliability of DSMs III and IV, a re-emphasis on validity is also strongly advocated. There is a recommendation to expand the number of validators from the five that were suggested by Robins and Guze (Robins and Guze, 1970) to eleven which would include neural substrates, familiality, genetic and environmental risk factors,
Conclusion
Despite difficulties in the current conceptualization of schizophrenia (Bentall, 2006) and its appropriate definition, abandoning the concept is not warranted at the present time. Patients diagnosed as suffering from schizophrenia have real disease—they experience both suffering and disability, their productivity is reduced, and the quality of their relationships is diminished. Although its precise pathogenesis remains to be clarified, schizophrenia is characterized by a range of
Disclosure statement
This statement was independently developed by Rajiv Tandon and Mario Maj. The content of the article is not part of the purview of Dr. Tandon’s current employment by the State of Florida which bears no responsibility for its contents. Rajiv Tandon is a member of the DSM-V workgroup on Schizophrenia and related psychotic disorders and the World Psychiatry Association Section of Pharmacopsychiatry and Mario Maj is the President of the World Psychiatry Association and participates in the ICD-11
References (57)
Madness explained: why we must reject the Kraepelinian paradigm and replace it with a ‘complaint-orientated’ approach to understanding mental illness
Med. Hypoth.
(2006)- et al.
Does schizoaffective disorder really exist? A systematic review of the studies that compared schizoaffective disorder with schizophrenia or mood disorders
J. Affective Disord.
(2008) - et al.
Reliability and validity of the DSM-IV diagnostic category of schizoaffective disorder: preliminary data
J. Affective Disord.
(2000) - et al.
Are we witnessing the disappearance of catatonic schizophrenia?
Comprehensive Psychiatry
(2002) - et al.
World Psychiatric Association Pharmacopsychiatry Section statement on comparative effectiveness of antipsychotics in the treatment of schizophrenia
Schizophr. Res.
(2008) - et al.
Schizophrenia “just the facts” what we know in 2008. 2. Epidemiology and etiology
Schizophr. Res.
(2008) - et al.
Schizophrenia “Just the Facts”: what we know in 2008 part 1: overview.
Schizophr. Res.
(2008) - et al.
Dimensions and the psychosis phenotype
Int. J. Methods Psychiatric Res.
(2007) Diagnostic and Statistical Manual of Mental Disorders, 1st edition (DSM-II)
(1952)Diagnostic and Statistical Manual of Mental Disorders, 2nd edition (DSM-II)
(1968)
Diagnostic and Statistical Manual of Mental Disorders, 3rd edition (DSM-III)
Diagnostic and Statistical Manual of Mental Disorders, 3rd edition (revised)
Diagnostic and Statistical Manual of Mental Disorders, 4th edition
Diagnostic and Statistical Manual of Mental Disorders, 4th edition (text revision) (DSM-IV-TR)
DSM and the death of phenomenology in America: an example of unintended consequences
Schizophr. Bull.
Classification of the causes of death
Dementia Praecox or the Group of Schizophrenias [1911]
Is schizophrenia what it was? A re-analysis of Kraeplin’s and Bleuler’s population
J. History Behav. Sci.
Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder
Schizophr. Bull.
Inclusion of cognitive impairment in the DSM diagnosis of schizophrenia: if not now, when?
World Psychiatry
Psychiatric diagnosis in New York and London
Toward defining schizophrenia as a more useful clinical concept
Curr. Psychiatry Rep.
Is cognitive impairment in schizophrenia ready for diagnostic prime time?
World Psychiatry
Cognition and the differential diagnosis of schizophrenia
World Psychiatry
One hundred years of schizophrenia: a meta-analysis of the outcome literature
Am. J. Psychiatry
Subtypes of schizophrenia: a cluster analytic approach
Can. J. Psychiatry
The concept of Schizophrenia Kraepelin-Bleuler-Schneider
Br. J. Psychiatry
Fifteen-year follow-up of ICD-10 schizoaffective disorders compared with schizophrenia and affective disorders
Acta Psychiatrica Scandinavica
Cited by (38)
Validity, Reliability and Clinical Utility of Mental Disorders: The Case of ICD-11 Schizophrenia
2022, Revista Colombiana de PsiquiatriaDisorganization and cognitive impairment in schizophrenia: New insights from electrophysiological findings
2019, International Journal of PsychophysiologyNew drug developments in psychosis: Challenges, opportunities and strategies
2017, Progress in NeurobiologySchizophrenia in DSM-5
2016, Annales Medico-Psychologiques